Integrated Bioinformatics Exploration and Preliminary Clinical Verification for the Identification of Crucial Biomarkers in Severe Cases of COVID-19

References

• World Health Organization. World Health Organization Coronavirus (COVID-19) Dashboard; 2023. Available from: https://covid19whoint/. Accessed March 04, 2024.
   Google Scholar
• Jiang L, Tang L, Zhu L, et al. Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness. J Infect. 2023;86(5):537–539. doi:10.1016/j.jinf.2022.11.026
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463–469. doi:10.1038/s41586-020-2588-y
   PubMed Web of Science ®Google Scholar
• Cao Y, Xu X, Kitanovski S, et al. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV infections: alternative entry routes and innate immune responses. Front Immunol. 2021;12:656433. doi:10.3389/fimmu.2021.656433
   PubMed Web of Science ®Google Scholar
• Smail SW, Babaei E, Amin K, Abdulahad WH. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients. Front Immunol. 2023;14:1145840. doi:10.3389/fimmu.2023.1145840
   PubMedGoogle Scholar
• Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–880. doi:10.1016/j.cell.2021.01.007
   PubMed Web of Science ®Google Scholar
• Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184(7):1671–1692. doi:10.1016/j.cell.2021.02.029
   PubMed Web of Science ®Google Scholar
• Nasrollahi H, Talepoor AG, Saleh Z, et al. Immune responses in mildly versus critically ill COVID-19 patients. Front Immunol. 2023;14:1077236. doi:10.3389/fimmu.2023.1077236
   PubMedGoogle Scholar
• Wilk AJ, Rustagi A, Zhao NQ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Med. 2020;26(7):1070–1076. doi:10.1038/s41591-020-0944-y
   PubMed Web of Science ®Google Scholar
• Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, Pelosi P, Rocco PRM. Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front Immunol. 2022;13:857573. doi:10.3389/fimmu.2022.857573
   PubMed Web of Science ®Google Scholar
• Aschenbrenner AC, Mouktaroudi M, Krämer B, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Gen Med. 2021;13(1):7. doi:10.1186/s13073-020-00823-5
   Google Scholar
• Meizlish ML, Pine AB, Bishai JD, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164–1177. doi:10.1182/bloodadvances.2020003568
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Prebensen C, Lefol Y, Myhre PL, et al. Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19. Sci Rep. 2023;13(1):10368. doi:10.1038/s41598-023-37606-y
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7). Chinese Med J. 2020;133(9):1087–1095. doi:10.1097/CM9.0000000000000819
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
   PubMed Web of Science ®Google Scholar
• Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322(1):C1–c11. doi:10.1152/ajpcell.00375.2021
   PubMed Web of Science ®Google Scholar
• Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863–876. doi:10.1016/S2213-2600(22)00126-6
   PubMed Web of Science ®Google Scholar
• Blanco JR, Cobos-Ceballos MJ, Navarro F, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021;27(6):892–896. doi:10.1016/j.cmi.2021.02.019
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Pekkarinen PT, Lakshmikanth T, et al. Systems-level immunomonitoring from acute to recovery phase of severe COVID-19. Cell Rep Med. 2020;1(5):100078. doi:10.1016/j.xcrm.2020.100078
   PubMedGoogle Scholar
• Liu S, Huang Z, Deng X, et al. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021;25(3):1725–1738. doi:10.1111/jcmm.16275
   PubMed Web of Science ®Google Scholar
• Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature Med. 2020;26(10):1636–1643. doi:10.1038/s41591-020-1051-9
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Cesta MC, Zippoli M, Marsiglia C, et al. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis. Eur J Immunol. 2023;53(1):e2250010. doi:10.1002/eji.202250010
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. Mol. Immunol. 2020;17(5):533–535. doi:10.1038/s41423-020-0402-2
   PubMed Web of Science ®Google Scholar
• Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4–17. doi:10.1016/j.ajpath.2020.08.009
   PubMed Web of Science ®Google Scholar
• Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Critical Care. 2022;26(1):14. doi:10.1186/s13054-021-03862-5
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–1520. doi:10.1016/S0140-6736(20)30920-X
   PubMed Web of Science ®Google Scholar
• Bruse N, Kooistra EJ, Jansen A, et al. Clinical sepsis phenotypes in critically ill COVID-19 patients. Critical Care. 2022;26(1):244. doi:10.1186/s13054-022-04118-6
   PubMed Web of Science ®Google Scholar
• Li K, Wang SW, Li Y, et al. Identification and expression of a new type II transmembrane protein in human mast cells. Genomics. 2005;86(1):68–75. doi:10.1016/j.ygeno.2005.03.006
   PubMed Web of Science ®Google Scholar
• Dahdah A, Gautier G, Attout T, et al. Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. J Clin Invest. 2014;124(10):4577–4589. doi:10.1172/JCI75212
   PubMed Web of Science ®Google Scholar
• Kong C, Zhu Y, Xie X, Wu J, Qian M. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study. Front Immunol. 2023;14:1184700. doi:10.3389/fimmu.2023.1184700
   PubMed Web of Science ®Google Scholar
• Chan KR, Koh CWT, Ng DH, et al. Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis. EBioMedicine. 2023;89:104472. doi:10.1016/j.ebiom.2023.104472
   PubMed Web of Science ®Google Scholar
• Len JS, Koh CWT, Chan KR. The functional roles of MDSCs in Severe COVID-19 pathogenesis. Viruses. 2023;16(1):27. doi:10.3390/v16010027
   PubMed Web of Science ®Google Scholar
• Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82(2):331–371. doi:10.1152/physrev.00030.2001
   PubMed Web of Science ®Google Scholar
• Toufiq M, Roelands J, Alfaki M, et al. Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data. Immunology. 2020;161(4):291–302. doi:10.1111/imm.13239
   PubMed Web of Science ®Google Scholar
• Yamanegi K, Yamada N, Nakasho K, Nishiura H. Participation of delta annexin A3 in the ribosomal protein S19 C-terminus-dependent inhibitory mechanism of the neutrophil C5a receptor through delta lactoferrin. Pathol Int. 2018;68(2):109–116. doi:10.1111/pin.12626
   PubMed Web of Science ®Google Scholar
• Du R, Liu B, Zhou L, et al. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer. Cell Death Dis. 2018;9(2):126. doi:10.1038/s41419-017-0143-z
   PubMedGoogle Scholar
• Smail SW, Babaei E, Amin K. Hematological, inflammatory, coagulation, and Oxidative/antioxidant biomarkers as predictors for severity and mortality in COVID-19: a prospective cohort-study. Int J Gene Med. 2023;16:565–580. doi:10.2147/IJGM.S402206
   PubMed Web of Science ®Google Scholar
• Mulet M, Osuna-Gómez R, Zamora C, et al. Dysregulated neutrophil extracellular traps formation in sepsis. Immunology. 2023;170(3):374–387. doi:10.1111/imm.13676
   PubMed Web of Science ®Google Scholar
• Tang BM, Shojaei M, Teoh S, et al. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun. 2019;10(1):3422. doi:10.1038/s41467-019-11249-y
   PubMedGoogle Scholar
• Demaret J, Venet F, Plassais J, et al. Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients. Immunol Lett. 2016;178:122–130. doi:10.1016/j.imlet.2016.08.011
   PubMed Web of Science ®Google Scholar
• Martínez-Paz P, Aragón-Camino M, Gómez-Sánchez E, et al. Gene expression patterns distinguish mortality risk in patients with postsurgical shock. J Clin Med. 2020;9(5):1276. doi:10.3390/jcm9051276
   PubMed Web of Science ®Google Scholar
• Juss JK, House D, Amour A, et al. Acute respiratory distress syndrome neutrophils have a distinct phenotype and are resistant to phosphoinositide 3-kinase inhibition. Am J Respir Crit Care Med. 2016;194(8):961–973. doi:10.1164/rccm.201509-1818OC
   PubMed Web of Science ®Google Scholar
• Smail SW, Babaei E, Amin K. Demographic, clinical and genetic factors associated with COVID-19 disease susceptibility and mortality in a Kurdish population. Ann Saudi Med. 2023;43(3):125–142. doi:10.5144/0256-4947.2023.125
   PubMed Web of Science ®Google Scholar
• Darbousset R, Thomas GM, Mezouar S, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood. 2012;120(10):2133–2143. doi:10.1182/blood-2012-06-437772
   PubMed Web of Science ®Google Scholar
• Huang WD, Lin YT, Tsai ZY, et al. Association between maternal age and outcomes in Kawasaki disease patients. Pediatr Rheumatol Online J. 2019;17(1):46. doi:10.1186/s12969-019-0348-z
   PubMedGoogle Scholar
• Jing Y, Ding M, Fu J, Xiao Y, Chen X, Zhang Q. Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC. Biosci Rep. 2020;40(9). doi:10.1042/BSR20200928
   Google Scholar
• Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. doi:10.1136/bmj.m2094
   PubMed Web of Science ®Google Scholar
• Lévy Y, Wiedemann A, Hejblum BP, et al. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death. iScience. 2021;24(7):102711. doi:10.1016/j.isci.2021.102711
   PubMed Web of Science ®Google Scholar
• Fuzo CA, Fraga-Silva TFC, Maruyama SR, et al. The turning point of COVID-19 severity is associated with a unique circulating neutrophil gene signature. Immunology. 2023;169(3):323–343. doi:10.1111/imm.13631
   PubMed Web of Science ®Google Scholar
• Bennett DL, Clark AJ, Huang J, Waxman SG, Dib-Hajj SD. The role of voltage-gated sodium channels in pain signaling. Physiol Rev. 2019;99(2):1079–1151. doi:10.1152/physrev.00052.2017
   PubMed Web of Science ®Google Scholar